< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 61
- Overcoming resistance to anti-PD1 blockade in uterine leiomyosarcomasFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Post-mortem tissue biobanking to illuminate end-stage ovarian cancer disease (ATLASOvCANCER)From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: BOF - ZAP BOF mandates
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Advisory Board Cancer Infertility Pregnancy (ABCIP)From1 Jan 2023 → 31 Dec 2023Funding: Other federal public and semi-governmental institutions
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Impact of prenatal exposure to cancer treatment during pregnancy and of chemotherapy for breast cancer on the brains: a multimodal MR imaging studyFrom1 Dec 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 583
- Long-term outcomes of children after prenatal exposure to maternal cancer and its treatment(2024)
Authors: Indra Van Assche, Frédéric Amant
- Results of an international survey on the current organization of care for pregnant women with cancer(2024)
Authors: Joosje Heimovaara, Kristel Van Calsteren, Frédéric Amant
- Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study.(2024)
Authors: Bernard Thienpont, Kristel Van Calsteren, Liesbeth Lenaerts, Frédéric Amant
Pages: e081833 - Sentinel lymph node biopsy for breast cancer during pregnancy: A comprehensive update(2024)
Authors: Frédéric Amant
- ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.(2024)
Authors: Frédéric Amant, Ignace Vergote
Pages: 248 - 266 - Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.(2024)
Authors: Frédéric Amant
Pages: ijgc-2023- - Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database(2024)
Authors: Joren Vanbraband, Frédéric Amant
Pages: 70 - 78 - Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI(2023)
Authors: Vincent Vandecaveye, Elleke Dresen, Els Van Nieuwenhuysen, Thaïs Baert, Frédéric Amant, Toon Van Gorp
Pages: 1890 - 1897 - Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk(2023)
Authors: Frédéric Amant
Pages: 1931 - 1944 - Non-invasive prenatal testing: when results suggests maternal cancer(2023)
Authors: Liesbeth Lenaerts, Miel Theunis, Frédéric Amant, Joris Vermeesch
Pages: 285 - 295